Screener
Acadia Pharmaceuticals ACAD Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $31.5M+18.1% | $3.64M-80.8% | $273.57M+90.3% | $71.78M+119% | $26.67M-20.1% | ||
| $434K+104% | $271K+18.3% | $202K-10.6% | $227K+0.4% | $213K-5.8% | ||
| $16.94M+18.1% | $14.7M+29.2% | $13.24M+26.7% | $13.18M-49.6% | $14.34M-8.6% | ||
| $100.78M+57.6% | $33.98M+67.2% | —— | $74.29M+17.5% | $63.96M+156% | ||
| $5.09M+1,613% | $5.21M— | $4.01M+784% | $388K+454% | $297K— | ||
| —— | $66.28M+153% | -$55.87M— | -$79.35M+3.8% | -$43.29M+23.0% | ||
| $10.49M-34.2% | $4.23M+130% | $22.67M+1,051% | $9.42M+3,416% | $15.96M+348% | ||
| $102.77M— | $104.52M+203% | -$81.93M-150% | —— | —— | ||
| $95.69M+50.3% | $28.77M+41.6% | —— | $73.9M+17.0% | $63.66M— |
FAQ
- How much cash does Acadia Pharmaceuticals generate?
- Acadia Pharmaceuticals (ACAD) generated $273.0M in operating cash flow over the trailing twelve months.
- What is Acadia Pharmaceuticals's free cash flow?
- After $14.7M of capital expenditures, Acadia Pharmaceuticals's free cash flow was $262.0M over the trailing twelve months, up 25.5% year over year.
- Where does Acadia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
